XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Revenue        
Revenue     $ 1,703 $ 7,551
Collaboration revenue        
Revenue        
Revenue     1,000 6,500
Collaboration revenue - upfront payment | License Agreement | Sinovant Sciences, LTD        
Revenue        
Revenue accounted for under Topic 606   $ 5,000   5,000
Collaboration revenue - upfront payment | License Agreement | Sunovion Pharmaceutics Canada, Inc.        
Revenue        
Revenue not accounted for under Topic 606 $ 1,000   1,000  
Collaboration revenue - Variable consideration | Clinical trial application submission        
Revenue        
Revenue accounted for under Topic 606     1,500  
Collaboration revenue - Variable consideration | License Agreement | Clinical trial application submission | Sinovant Sciences, LTD        
Revenue        
Revenue accounted for under Topic 606       1,500
Research premium        
Revenue        
Revenue     393 770
Government grants        
Revenue        
Revenue     $ 311 $ 281